Advanced Oxygen Techs (AOXY) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 5, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-K for FY2026, filed Sep 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AOXY SEC filings page.
Advanced Oxygen Techs Inc (AOXY) reported $47K in revenue for fiscal year 2026, up 9.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
FY2026 growth is modest operationally, while a large tax benefit makes reported profit look far stronger than cash generation.
Earnings quality diverged sharply: net income jumped2388.4% , but operating cash flow rose only27.1% . The gap reflects a reported income-tax expense of-$86.6K , making the profit surge primarily a tax-line event rather than an operating one.
The balance sheet became less debt-dependent: long-term debt fell from
Revenue grew
Financial Health Signals
We do not publish a peer-relative financial health score for Advanced Oxygen Techs Inc, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Advanced Oxygen Techs Inc scores -42.91, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $20.6M against total assets of $657K. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Advanced Oxygen Techs Inc passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) passes.
For every $1 of reported earnings, Advanced Oxygen Techs Inc generates $0.50 in operating cash flow ($51K OCF vs $103K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Earnings & Revenue
Advanced Oxygen Techs Inc generated $12K in revenue in Q4 2026. This represents an increase of 36.8% from the same quarter a year earlier. Against the prior quarter it is down 0.7%.
Advanced Oxygen Techs Inc reported $100K in net income in Q4 2026. This represents an increase of 15500.8% from the same quarter a year earlier. Against the prior quarter it is up 2805.1%.
Advanced Oxygen Techs Inc earned $0.03 per diluted share (EPS) in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Not reported for Q4 2026.
Cash & Balance Sheet
Advanced Oxygen Techs Inc held $39K in cash against $0 in long-term debt as of Q4 2026.
Not reported for Q4 2026.
Not reported for Q4 2026.
Margins & Returns
Advanced Oxygen Techs Inc's operating margin was 51.0% in Q4 2026, reflecting core business profitability. This is up 15.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Advanced Oxygen Techs Inc's quarterly ROE was 20.3% in Q4 2026: one quarter's net income over shareholder equity, not annualized. This is up 20.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 19.4 percentage points.
Not reported for Q4 2026.
Not shown for Q4 2026: the reported ratio is above 100.0% of revenue, so it does not read as a share of revenue.
Capital Allocation
None of these metrics is reported for Q4 2026.
AOXY Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12K+36.8% | $12K+13.5% | $12K-11.6% | $12K+8.2% | $9K-18.3% | $11K-1.7% | $13K+26.2% | $11K+2.4% |
| SG&A Expenses | $1K-17.0% | $1K-1.8% | $2K+35.6% | $1K-36.6% | $2K-3.2% | $1K+7.5% | $2K-9.2% | $2K+7.1% |
| Operating Income | $6K+96.4% | $6K+18.7% | $5K-33.2% | -$973n/m | $3K-38.0% | $5K-5.3% | $8K+60.2% | -$2Kn/m |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | $352-3.0% | $0-100.0% |
| Income Tax | -$94K-3933.1% | $3K+14.1% | $3K-14.3% | $2K+7.4% | $2K+7.7% | $2K-20.5% | $3K+66.0% | $2K+1.9% |
| Net Income | $100K+15500.8% | $3K+22.5% | $3K-48.6% | -$3Kn/m | $643-76.3% | $3K+11.8% | $5K+50.0% | -$4Kn/m |
| EPS (Basic) | $0.03n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| EPS (Diluted) | $0.03n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m | $0.00n/m |
| Diluted Shares (Avg) | N/A | 3M0.0% | 3M0.0% | 3M0.0% | N/A | 3M0.0% | 3M0.0% | 3M0.0% |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, EBITDA.
AOXY Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $657K-5.2% | $655K+1.6% | $670K+6.5% | $681K-1.8% | $693K+2.6% | $645K-6.7% | $629K-11.2% | $694K+2.9% |
| Current Assets | $40K-30.8% | $36K-39.1% | $35K-46.4% | $47K-47.6% | $58K-38.8% | $59K-44.7% | $66K-39.8% | $89K-13.0% |
| Cash & Equivalents | $39K-31.4% | $35K-40.0% | $34K-47.4% | $46K-48.2% | $57K-39.4% | $58K-45.2% | $65K-40.2% | $88K-13.2% |
| Short-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Long-Term Investments | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m | $0n/m |
| Total Liabilities | $164K-41.0% | $256K-12.1% | $254K-17.2% | $268K-17.6% | $277K-16.7% | $291K-15.7% | $307K-11.8% | $326K-6.9% |
| Current Liabilities | $37K-75.7% | $256K-12.1% | $254K-17.2% | $268K-17.6% | $150K-27.1% | $291K-15.7% | $307K-11.8% | $326K-6.9% |
| Non-Current Liabilities | $127K0.0% | $0n/m | $0n/m | $0n/m | $127K0.0% | $0n/m | $0n/m | $0n/m |
| Long-Term Debt | $0n/m | $0n/m | $0-100.0% | $0-100.0% | $0-100.0% | $0-100.0% | $127K0.0% | $127K-1.8% |
| Total Equity | $494K+18.8% | $399K+12.9% | $416K+29.2% | $413K+12.1% | $416K+21.5% | $353K+2.4% | $322K-10.7% | $368K+13.5% |
| Retained Earnings | -$20.6Mn/m | -$20.7Mn/m | -$20.8Mn/m | -$20.8Mn/m | -$20.8Mn/m | -$20.8Mn/m | -$20.8Mn/m | -$20.8Mn/m |
Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill.
AOXY Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Dividends Paid, Share Buybacks.
AOXY Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2610-K | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 51.0%+15.5pp | 50.4%+2.2pp | 44.1%-14.3pp | -8.3%+11.7pp | 35.5%-11.3pp | 48.2%-1.9pp | 58.4%+12.4pp | -20.0%-12.7pp |
| Net Margin | 841.0% | 28.7%+2.1pp | 22.6%-16.3pp | -29.2%+11.9pp | 7.4%-18.1pp | 26.6%+3.2pp | 38.9%+6.2pp | -41.1%-11.9pp |
| Return on Equity | 20.3%+20.2pp | 0.9%+0.1pp | 0.6%-1.0pp | -0.8%+0.4pp | 0.1%-0.6pp | 0.8%+0.1pp | 1.6%+0.7pp | -1.2%-0.3pp |
| Return on Assets | 15.3%+15.2pp | 0.5%+0.1pp | 0.4%-0.4pp | -0.5%+0.1pp | 0.1%-0.3pp | 0.4%+0.1pp | 0.8%+0.3pp | -0.6%-0.2pp |
| Current Ratio | 1.11+0.7x | 0.14-0.1x | 0.14-0.1x | 0.17-0.1x | 0.39-0.1x | 0.20-0.1x | 0.21-0.1x | 0.270.0x |
| Debt-to-Equity | 0.000.0x | 0.000.0x | 0.00-0.4x | 0.00-0.3x | 0.00-0.4x | 0.00-0.4x | 0.390.0x | 0.35-0.1x |
| Liabilities-to-Equity | 0.33-0.3x | 0.64-0.2x | 0.61-0.3x | 0.65-0.2x | 0.67-0.3x | 0.83-0.2x | 0.950.0x | 0.88-0.2x |
| Asset Turnover | 0.020.0x | 0.020.0x | 0.020.0x | 0.020.0x | 0.010.0x | 0.020.0x | 0.020.0x | 0.020.0x |
Not reported in any period shown, so not listed: Gross Margin, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Advanced Oxygen Techs Inc AOXY | FY2026 | $47K | $103K | N/A | $250K | — |
| Cannabis Suisse Corp CSUI | FY2026 | $0 | $123K | N/A | $544K | — |
Where Advanced Oxygen Techs Inc Ranks
Frequently Asked Questions
Advanced Oxygen Techs Inc (AOXY) reported $47K in total revenue for fiscal year 2026. This represents a 9.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Advanced Oxygen Techs Inc (AOXY) revenue grew by 9.2% year-over-year, from $43K to $47K in fiscal year 2026.
Yes, Advanced Oxygen Techs Inc (AOXY) reported a net income of $103K in fiscal year 2026.
As of fiscal year 2026, Advanced Oxygen Techs Inc (AOXY) had $39K in cash and equivalents against $0 in long-term debt.
Advanced Oxygen Techs Inc (AOXY) had an operating margin of 34.4% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.
Advanced Oxygen Techs Inc (AOXY) has a return on equity of 20.9% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.
Advanced Oxygen Techs Inc (AOXY) generated $51K in operating cash flow during fiscal year 2026, representing cash generated from core business activities.
Advanced Oxygen Techs Inc (AOXY) had $657K in total assets as of fiscal year 2026, including both current and long-term assets.
Advanced Oxygen Techs Inc (AOXY) had a current ratio of 1.11 as of fiscal year 2026, which is considered adequate.
Advanced Oxygen Techs Inc (AOXY) had a debt-to-equity ratio of 0.00 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Advanced Oxygen Techs Inc (AOXY) had a liabilities-to-equity ratio of 0.33 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Advanced Oxygen Techs Inc (AOXY) had a return on assets of 15.7% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.
Advanced Oxygen Techs Inc (AOXY) trades at 2.4x earnings, its market capitalization divided by $103K net income, FY2026. The market capitalization is $250K as of Nov 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Advanced Oxygen Techs Inc (AOXY) trades at 5.3x sales, its market capitalization divided by $47K revenue, FY2026. The market capitalization is $250K as of Nov 5, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
Advanced Oxygen Techs Inc (AOXY) has an Altman Z-Score of -42.91, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Advanced Oxygen Techs Inc (AOXY) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Advanced Oxygen Techs Inc (AOXY) has an earnings quality ratio of 0.50x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.